Canada markets close in 1 hour 38 minutes

NeutriSci International Inc. (1N9.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.1140+0.0050 (+4.59%)
As of 2:59PM CEST. Market open.
Full screen
Previous Close0.1090
Open0.0956
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0956 - 0.1140
52 Week Range0.0325 - 0.2360
Volume49,000
Avg. Volume21,259
Market Cap17.546M
Beta (5Y Monthly)2.48
PE Ratio (TTM)N/A
EPS (TTM)-0.0090
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    Neutrisci Ships Tabletz Rush Order to #1 CBD Retailer in Japan

    VANCOUVER, BC / ACCESSWIRE / June 9, 2021 / NeutriSci International Inc. ('NeutriSci' or the 'Company') (TSXV:NU)(OTCQB:NRXCF)(FSE:1N9), an innovative technology company developing products, licensing IP and technology for B2B partnerships and the nutraceutical industry, is pleased to announce that it has finished production of the rush order placed by Tabletz LLC and shipped it via air freight to Japan.

  • NeutriSci Completes R&D and Expands Product Selection to Include Beverages
    ACCESSWIRE

    NeutriSci Completes R&D and Expands Product Selection to Include Beverages

    VANCOUVER, BC / ACCESSWIRE / May 27, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU, OTCQB:NRXCF, FRANKFURT: 1N9), an innovative technology company developing products, licensing IP and technology for B2B partnerships and the nutraceutical industry, is pleased to announce that it has completed the R&D required to successfully create functional beverages using its IP and Technology to enter the CBD beverage market.

  • NeutriSci and Pacwest Announce Technology and IP Arrangement for R&D Product Development
    ACCESSWIRE

    NeutriSci and Pacwest Announce Technology and IP Arrangement for R&D Product Development

    VANCOUVER, BC / ACCESSWIRE / May 25, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRA:1N9), an innovative technology company developing products, licencing IP and technology for B2B partnerships and the nutraceutical industry, is pleased to announce the completion of an arrangement with its manufacturing partner, Pacwest Manufacturing Group Inc.